Gritstone Bio Analyst Ratings
Gritstone Bio Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/10/2023 | 300% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 05/15/2023 | 300% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 03/28/2023 | 357.14% | B. Riley Securities | → $8 | Initiates Coverage On | → Buy |
| 03/14/2023 | 300% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/15/2023 | 300% | HC Wainwright & Co. | → $7 | Maintains | Buy |
| 11/07/2022 | 300% | HC Wainwright & Co. | $12 → $7 | Maintains | Buy |
| 10/31/2022 | 242.86% | Piper Sandler | → $6 | Initiates Coverage On | → Overweight |
| 08/22/2022 | 14.29% | Goldman Sachs | → $2 | Downgrades | Neutral → Sell |
| 05/09/2022 | 585.71% | HC Wainwright & Co. | $15 → $12 | Maintains | Buy |
| 03/14/2022 | 757.14% | HC Wainwright & Co. | $24 → $15 | Maintains | Buy |
| 01/20/2021 | 357.14% | Baird | → $8 | Downgrades | Outperform → Underperform |
| 01/20/2021 | 1271.43% | HC Wainwright & Co. | $16 → $24 | Maintains | Buy |
| 07/14/2020 | 871.43% | BTIG | $31 → $17 | Maintains | Buy |
| 07/26/2019 | 871.43% | Baird | → $17 | Initiates Coverage On | → Outperform |
| 03/15/2019 | 1042.86% | Raymond James | → $20 | Initiates Coverage On | → Outperform |
| 03/07/2019 | 871.43% | HC Wainwright & Co. | → $17 | Initiates Coverage On | → Buy |
| 10/23/2018 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 10/23/2018 | 928.57% | Goldman Sachs | → $18 | Initiates Coverage On | → Neutral |
| 10/23/2018 | 1385.71% | BTIG | → $26 | Initiates Coverage On | → Buy |
| 10/23/2018 | 1328.57% | Barclays | → $25 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/10/2023 | 300% | HC Wainwright & Co. | → 7 美元 | 重申 | 購買 → 購買 |
| 05/15/2023 | 300% | HC Wainwright & Co. | → 7 美元 | 重申 | 購買 → 購買 |
| 03/28/2023 | 357.14% | B. 萊利證券 | → 8 美元 | 啓動覆蓋開啓 | → 購買 |
| 03/14/2023 | 300% | HC Wainwright & Co. | → 7 美元 | 重申 | → 購買 |
| 02/15/2023 | 300% | HC Wainwright & Co. | → 7 美元 | 維護 | 購買 |
| 2022 年 7 月 11 日 | 300% | HC Wainwright & Co. | 12 美元 → 7 美元 | 維護 | 購買 |
| 10/31/2022 | 242.86% | 派珀·桑德勒 | → 6 美元 | 啓動覆蓋開啓 | → 超重 |
| 2022 年 8 月 22 日 | 14.29% | 高盛 | → 2 美元 | 降級 | 中性 → 賣出 |
| 05/09/2022 | 585.71% | HC Wainwright & Co. | 15 美元 → 12 美元 | 維護 | 購買 |
| 03/14/2022 | 757.14% | HC Wainwright & Co. | 24 美元 → 15 美元 | 維護 | 購買 |
| 2021 年 1 月 20 日 | 357.14% | 貝爾德 | → 8 美元 | 降級 | 跑贏大盤 → 表現不佳 |
| 2021 年 1 月 20 日 | 1271.43% | HC Wainwright & Co. | 16 美元 → 24 美元 | 維護 | 購買 |
| 2020 年 7 月 14 日 | 871.43% | BTIG | 31 美元 → 17 美元 | 維護 | 購買 |
| 07/26/2019 | 871.43% | 貝爾德 | → 17 美元 | 啓動覆蓋開啓 | → 跑贏大盤 |
| 03/15/2019 | 1042.86% | 雷蒙德·詹姆 | → 20 美元 | 啓動覆蓋開啓 | → 跑贏大盤 |
| 2019 年 7 月 3 日 | 871.43% | HC Wainwright & Co. | → 17 美元 | 啓動覆蓋開啓 | → 購買 |
| 10/23/2018 | — | Cowen & Co. | 啓動覆蓋開啓 | → 跑贏大盤 | |
| 10/23/2018 | 928.57% | 高盛 | → 18 美元 | 啓動覆蓋開啓 | → 中立 |
| 10/23/2018 | 1385.71% | BTIG | → 26 美元 | 啓動覆蓋開啓 | → 購買 |
| 10/23/2018 | 1328.57% | 巴克萊 | → 25 美元 | 啓動覆蓋開啓 | → 超重 |
What is the target price for Gritstone Bio (GRTS)?
Gritstone Bio（GRTS）的目標價格是多少？
The latest price target for Gritstone Bio (NASDAQ: GRTS) was reported by HC Wainwright & Co. on August 10, 2023. The analyst firm set a price target for $7.00 expecting GRTS to rise to within 12 months (a possible 300.00% upside). 8 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年8月10日公佈了Gritstone Bio（納斯達克股票代碼：GRTS）的最新目標股價。這家分析公司將目標股價定爲7.00美元，預計GRTS將在12個月內升至7.00美元（可能上漲300.00％）。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for Gritstone Bio (GRTS)?
分析師對Gritstone Bio（GRTS）的最新評級是多少？
The latest analyst rating for Gritstone Bio (NASDAQ: GRTS) was provided by HC Wainwright & Co., and Gritstone Bio reiterated their buy rating.
Gritstone Bio（納斯達克股票代碼：GRTS）的最新分析師評級由HC Wainwright & Co. 提供，Gritstone Bio重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Gritstone Bio (GRTS)?
Gritstone Bio（GRTS）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gritstone Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gritstone Bio was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與Gritstone Bio的高管和客戶交談以及聽取業績電話會議）後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Gritstone Bio的最後一次評級是在2023年8月10日提交的，因此您應該預計下一個評級將在2024年8月10日左右公佈。
Is the Analyst Rating Gritstone Bio (GRTS) correct?
分析師對 Gritstone Bio (GRTS) 的評級正確嗎？
While ratings are subjective and will change, the latest Gritstone Bio (GRTS) rating was a reiterated with a price target of $0.00 to $7.00. The current price Gritstone Bio (GRTS) is trading at is $1.75, which is within the analyst's predicted range.
雖然評級是主觀的，會發生變化，但最新的Gritstone Bio（GRTS）評級得到了重申，目標股價爲0.00美元至7.00美元。Gritstone Bio（GRTS）目前的交易價格爲1.75美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。